CHAMPIONS ONCOLOGY INC (CSBR) Stock Analyst Ratings
NASDAQ:CSBR - Nasdaq - US15870P3073 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CSBR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is -19.76% below the current price.
CSBR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CSBR.
In the previous month the buy percentage consensus was at a similar level.
CSBR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-12 | Craig-Hallum | Upgrade | Hold -> Buy |
| 2024-03-13 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2023-09-22 | Roth MKM | Maintains | Buy -> Buy |
| 2021-03-15 | Roth Capital | Maintains | Buy |